|
2026
|
G/S
|
Medicaments, namely, polypeptides, for use in the treatment of tumorous diseases, cancer, allergi... |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hemat... |
|
|
G/S
|
Promoting public awareness of osteoporosis, management of osteoporosis and fracture risk reductio... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of diabetes,
endocrine diseases and disorders, met... |
|
|
G/S
|
Providing online non-downloadable informational content in the field of musculoskeletal health an... |
|
|
G/S
|
Pharmaceutical preparations for treating alopecia, Alzheimer's disease, atopic dermatitis, autoim... |
|
|
G/S
|
Pharmaceutical preparations for treating alopecia,
Alzheimer's disease, atopic dermatitis, autoi... |
|
|
G/S
|
Pharmaceutical preparations for treating alopecia,
alzheimer's disease, atopic dermatitis, autoi... |
|
|
G/S
|
Retail pharmacy services, namely, retail services for pharmaceuticals, pharmaceutical preparation... |
|
|
G/S
|
Pharmacy services; online retail pharmacy services; mail order pharmacy services; online retail s... |
|
|
G/S
|
pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceuti... |
|
|
G/S
|
pharmaceutical preparations;pharmaceutical preparations for the treatment of cancer;pharmaceutica... |
|
|
G/S
|
educational services, namely development and dissemination of educational materials in the field ... |
|
|
Invention
|
Data-driven predictive modeling for cell line selection in biopharmaceutical production.
A metho... |
|
|
Invention
|
Combination therapy including a kras g12c inhibitor and one or more additional pharmaceutically a... |
|
|
G/S
|
Pharmaceutical preparations for treating cancer and oncological disorders; Pharmaceutical prepara... |
|
|
Invention
|
Hybrid predictive modeling for control of cell culture.
A method of controlling a cell culture p... |
|
|
G/S
|
Injectors for medical purposes pre-filled with pharmaceutical preparations for treating cancer, i... |
|
2025
|
Invention
|
Convergent peptide synthesis methods.
Convergent pathways for the preparation of a peptide by so... |
|
|
Invention
|
Convergent peptide synthesis methods. Convergent pathways for the preparation of a peptide by sol... |
|
|
Invention
|
T cell engager masking molecules with reduced isomerization tendencies. The present invention rel... |
|
|
Invention
|
Methods of diethylenetriaminepentaacetic acid (dtpa) quantification. Provided herein are methods ... |
|
|
Invention
|
Drug delivery devices and flange extension members. Drug delivery devices and flange extension me... |
|
|
Invention
|
Polycyclic compounds as modulators of stat6 and uses thereof. Disclosed herein are compounds usef... |
|
|
Invention
|
Compounds as modulators of stat6 and uses thereof.
Disclosed herein are compounds useful for the... |
|
|
Invention
|
Therapeutic compositions, combinations, and methods of use. This disclosure relates to methods of... |
|
|
Invention
|
Load vessel draining system and method. A load vessel draining system for use with a drug purific... |
|
|
Invention
|
Biological detection systems and methods for setting medically suitable target ranges of attribut... |
|
|
Invention
|
Next-generation sequencing platform for sequence variant analysis of manufacturing cell lines. Me... |
|
|
Invention
|
Bispecific lymphotoxin b receptor binding proteins. The present disclosure is directed to bispeci... |
|
|
Invention
|
Titration doses of maridebart cafraglutide. The present invention relates to methods of treating ... |
|
|
Invention
|
Drive assembly for a drug delivery device and related methods. Drive assemblies for a drug delive... |
|
|
Invention
|
Drive assembly for a drug delivery device and related methods.
Drive assemblies for a drug deliv... |
|
|
Invention
|
Methods of treating obesity and obesity-related conditions. The present invention relates to meth... |
|
|
Invention
|
Systems and methods for inspecting drug containers. Systems and methods for inspecting one or mor... |
|
|
Invention
|
Harmaceutica formulations comprising a monoclonal antibody.
The present invention relates to met... |
|
|
Invention
|
Combination therapy of a prmt5 inhibitor and daraxonrasib for use in the treatment of mtap-null c... |
|
|
Invention
|
5,6-fused bicyclic alcohol compounds as 15-prostaglandin dehydrogenase modulators. Disclosed here... |
|
|
Invention
|
5,6-fused bicyclic alcohol compounds as 15-prostaglandin dehydrogenase modulators.
Disclosed her... |
|
|
Invention
|
Drug delivery device and related methods. A drug delivery device (10, 100, 200) which includes a ... |
|
|
Invention
|
Proteins specific for baff and b7rp1 and uses thereof.
Described herein are bispecific proteins ... |
|
|
Invention
|
Synthetic processes for pharmaceutically active compounds. 2 2 to afford a compound of Compound 1. |
|
|
Invention
|
Chimeric receptors to steap1 and methods of use thereof.
Antigen binding molecules, chimeric rec... |
|
|
Invention
|
Sotorasib dosing regimen.
The present disclosure provides method of administering sotorasib to a... |
|
|
Invention
|
Methods for increasing mannose content of recombinant proteins.
The present invention relates to... |
|
|
Invention
|
Solid state forms.
The present disclosure provides crystalline and amorphous forms of 6-fluoro-7... |
|
|
Invention
|
Disruption of vascular smooth muscle relaxation by carfilzomib may be the primary reason for cfz-... |
|
|
Invention
|
Solid forms of macrocyclic compounds and uses thereof.
The disclosure provides solid forms of Co... |
|
2023
|
Invention
|
Solid forms of naphthyridine compounds.
Disclosed herein are various solid forms of Compound A, ... |
|
|
Invention
|
Cancer treatments using mta-cooperative prmt5 inhibitors and mat2a inhibitors.
Described herein ... |
|
|
Invention
|
Selection of patients for the treatment of fads1-mediated diseases or disorders using fads-1 inhi... |
|
|
Invention
|
Macrocyclic compounds and methods of use.
The present disclosure provides compounds useful for t... |
|
|
Invention
|
Methods for treating obesity.
The present invention relates to methods of treating obesity or ty... |
|
|
Invention
|
Systems and methods for performing line clearance and monitoring.
Systems and methods of perform... |
|
|
Invention
|
Compositions of anti-interleukin 12/interleukin 23 antibody.
Pharmaceutical compositions compris... |
|
|
Invention
|
Anti-tslp antibody compositions and uses thereof.
The present application relates, in general, t... |
|
|
Invention
|
Tethered heterocyclic inhibitors of kras g12c mutant proteins and uses thereof.
The present disc... |
|
|
Invention
|
Heterocyclic inhibitors of kras g12c mutant proteins and uses thereof.
The present disclosure pr... |
|
|
Invention
|
Methods of treating cancer.
Provided herein are methods of treating a cancer in a patient wherei... |
|
2022
|
Invention
|
Drug delivery devices, components for use within drug delivery devices, and methods of operating ... |
|
|
Invention
|
Deep learning-based prediction using spectroscopy.
A method for monitoring and/or controlling a ... |
|
2021
|
Invention
|
Polypeptide constructs selectively binding to cldn6 and cd3.
The present invention relates to a ... |
|
2020
|
Invention
|
Systems and methods for preparing a sample and performing a real-time assay of the sample |
|
2012
|
Invention
|
Methods and apparati for nondestructive detection of undissolved particles in a fluid. An apparat... |
|
|
Invention
|
Autoinjector apparatus. An apparatus for injection of a therapeutic product, the apparatus compri... |
